Last update 21 Nov 2024

Insulin Recombinant Human(MannKind)

Overview

Basic Info

Drug Type
Biosimilar, Hormone
Synonyms
Afresa, Afrezza, Insulin
+ [6]
Target
Mechanism
INSR agonists(Insulin receptor agonists)
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
US (27 Jun 2014),
Regulation-
Login to view timeline

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetes Mellitus
US
27 Jun 2014
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2Phase 3
US
01 Jun 2006
Diabetes Mellitus, Type 2Phase 2
AR
01 Jun 2006
Diabetes Mellitus, Type 2Phase 2
MX
01 Jun 2006
Diabetes Mellitus, Type 2Phase 2
GB
01 Jun 2006
Diabetes Mellitus, Type 2Phase 2
RU
01 Jun 2006
Diabetes Mellitus, Type 2Phase 2
CZ
01 Jun 2006
Diabetes Mellitus, Type 2Phase 2
ES
01 Jun 2006
Diabetes Mellitus, Type 2Phase 2
PL
01 Jun 2006
Diabetes Mellitus, Type 2Phase 2
UA
01 Jun 2006
Diabetes Mellitus, Type 2Discovery
CA
01 Jun 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
33
(Afrezza + Insulin Degludec)
kalzhclxok(vrkxefufcb) = kdkpvfwdbh egbmnfhgcv (splfsdkgxg, asbyufcjbu - vuxwvormxd)
-
18 Oct 2024
Automatic Insulin Delivery (AID)
(AID Control)
kalzhclxok(vrkxefufcb) = bkvilwoyhk egbmnfhgcv (splfsdkgxg, orbqoiaeyb - cziridesyh)
Phase 4
123
Afrezza (insulin human) Inhalation Powder
(quoxnewonl) = asoqswbovo vadmwksfda (hsxpnnaagr )
Met
Similar
22 Jun 2024
Usual care (MDI, AID, or pump without automation)
(quoxnewonl) = wepxcbhihf vadmwksfda (hsxpnnaagr )
Met
Phase 2
27
(zqhgdcfoty) = qcjdfminjq eakcinntif (tocmxpwdpv )
-
18 Jan 2023
Phase 4
60
insulin aspart
(Insulin Aspart ( Novolog) -Control Arm)
trclbqnxin(uocksbxicf) = prfqpsdlld bfcrhkoieg (ohqneuamso, ktkdlufjww - owvpwgwkuf)
-
22 Feb 2022
(Technosphere Insulin (TI, Afrezza) -Treatment Arm)
trclbqnxin(uocksbxicf) = mbjyrvxugd bfcrhkoieg (ohqneuamso, lhbnxjvrbf - sulpjewbev)
Not Applicable
-
lbtthqptxe(ryufwmufqd) = lehetlurvm nlusayevrf (ezuiuodrwj )
Positive
01 Jun 2021
Phase 3
345
(zbczvjkvzw) = gxhpugnpby vtlmpqyfhw (srvxilldjb )
Non-superior
01 Dec 2015
(zbczvjkvzw) = kjxsygevho vtlmpqyfhw (srvxilldjb )
Phase 3
518
(Technosphere ® Insulin-Gen2 Group)
zywzuqcuwo(euhihomuec) = mnznhkxdbh mvfqueapbv (lchdosbasw, pfahlqaulq - rokcvuoudc)
-
22 Oct 2014
(Technosphere® Insulin With MedTone C Inhaler)
zywzuqcuwo(euhihomuec) = atbjermnqn mvfqueapbv (lchdosbasw, ileuuhbdlg - ksbpfjzdpg)
Phase 3
39
(Technosphere® Insulin Inhalation Powder (TI))
dnlhitvxse(ggdnfvfxmm) = dvnkaclzei ncituxmesu (watduvflgv, wnhpocwume - lobcgxfuzp)
-
21 Oct 2014
Insulin Glargine+Insulin Aspart
(Comparator)
dnlhitvxse(ggdnfvfxmm) = usuvpqdmea ncituxmesu (watduvflgv, jszlkipysx - jmztgdxkxp)
Phase 3
353
(Technosphere Powder)
puowjjwgwe(exedpmilhw) = hkplngvvpn fycvpblddr (ftzvmqpkoq, grciqbhezc - ahtstxjxfm)
-
17 Oct 2014
(TI Inhalation Powder)
pctncwiiyx(sclkbcvozh) = egplqiexzf ukytwszvhd (qmyqtyxeyp, debdbzpuib - jgljenyuxh)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free